VR Logo

Elanco Animal Health Incorporated (ELAN) download report


Healthcare | Drugs & Pharma

Elanco Animal Health Incorporated (ELAN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.

IPO Date: 20-Sep-2018

Pres, CEO & Director: Mr. Jeffrey N. Simmons

Exec. VP of Corp. Governance and Strategy & CFO: Mr. Todd S. Young

Listing: NYSE: ELAN

Country: United States

Headquarters: Greenfield, IN

Website: https://www.elanco.com

Key Facts

Market cap: $9,481.92 Mln

Revenue (TTM): $4,748.00 Mln

Earnings (TTM): $-363.00 Mln

Cash: $342.00 Mln

Total Debt: $6,134.00 Mln

Insider's Holding: 4.13%

Liquidity: Low

52 Week range: $19.34 - 37.49

Shares outstanding: 474,096,000

7 Years Aggregate:

  • CFO: $1,489.70 Mln
  • EBITDA: $1,428.60 Mln
  • Net Profit: $-1,447.10 Mln

Stock Performance

Time Period Elanco Animal Health (ELAN) S&P BSE Healthcare S&P Midcap 400
YTD-27.34-17.04-19.22
1 month-13.62-3.24-8.89
3 months-20.97-10.55-14.77
1 Year-40.56-15.04-14.84
3 Years-15.1919.035.68
5 Years--8.915.62
10 Years--12.199.32
As on 01-Jul-2022
Year Elanco Animal Health (ELAN) S&P Midcap 400 S&P BSE Healthcare
2021-7.4723.2120.87
20204.1411.8161.45
2019-6.6024.05-3.55